Generic substitution: Additional challenge for adherence in hypertensive patients?

Current Medical Research and Opinion

Volumn 25, Issue 10, 2009, Pages 2515-2521

  Håkonsen, Helle ^a   Eilertsen, Marlene ^a   Borge, Hilde ^a   Toverud, Else Lydia ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Adherence; Compliance; Cost containment; Generic drugs; Generic substitution; Hypertension; Patient safety

Indexed keywords

ANTIHYPERTENSIVE AGENT; GENERIC DRUG;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; DRUG EFFECT; DRUG INFORMATION; DRUG SUBSTITUTION; DRUG USE; EDUCATIONAL STATUS; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICATION ERROR; PATIENT ATTITUDE; PATIENT COMPLIANCE; PHARMACY; PRESCRIPTION; QUESTIONNAIRE; SEMI STRUCTURED INTERVIEW; UNSPECIFIED SIDE EFFECT;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DRUGS, GENERIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NORWAY; PATIENT COMPLIANCE; QUESTIONNAIRES;

EID: 70349316577     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007990903192223     Document Type: Article

References (29)

1. Andersson K, Bergström G, Petzold MG, et al. Impact of a generic substitution reform on patients' and society's expenditure for pharmaceuticals. Health Policy 2007;81:376-384 (Pubitemid 46436192)
2. Gumbs PD, Verschuren WMM, Souverein PC, et al. Society already achieves economic benefits from generic substitution but fails to do the same for therapeutic substitution. Br J Clin Pharmacol 2007;64:680-685
3. Håkonsen H, Horn AM, Toverud EL. Price control as a strategy for pharmaceutical cost containment - what has been achieved in Norway in the period 1994-2004? Health Policy 2009;90:277-285
4. Morgan SG, Agnew JD, Barer ML. Seniors' prescription drug cost inflation and cost containment: evidence from British Columbia. Health Policy 2004;68:299-307
5. The Norwegian Association of Pharmaceutical Manufacturers. Facts and Figures 2009. http://www.legemiddelstatistikk.com/tf/2009/index.html [Accessed 28.04.2009]
6. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO, 2003
7. Morris LS, Schulz RM. Patient compliance - an overview. J Clin Pharm Ther 1992;17:283-295
8. Burnier M, Santschi V, Favrat B, et al. Monitoring compliance in resistant hypertension: an important step in patient management. J Hypertens Suppl 2003;21:S37-42 (Pubitemid 36900681)
9. Chobanian AV, Bakris GL, Black HR, et al, National High Blood Pressure Education Program Coordinating Committee. Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003;42:1206-1252
10. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003;290:199-206
11. Barrett JS, Batra V, Chow A, et al. PhRMA perspective on population and individual bioequivalence. J Clin Pharmacol 2000;40:561-570
12. Nakai K, Fujita M, Ogata H. International harmonization of bioequivalence studies and issues shared in common. Yakugaku Zasshi 2000;120:1193-1200
13. Ganther JM, Kreling DH. Consumer perceptions of risk and required cost savings for generic prescription drugs. J Am Pharm Assoc 2000;40:378-383
14. Himmel W, Simmenroth-Nayda A, Niebling W, et al. What do primary care patients think about generic drugs? Int J Clin Pharmacol Ther 2005;43:472-479
15. Kjoenniksen I, Lindbaek M, Granas AG. Patients' attitudes towards and experiences of generic drug substitution in Norway. Pharm World Sci 2006;28:284-289 (Pubitemid 44875826)
16. Andersen MLE, Laursen K, Schaumann M, et al. How do patients evaluate the newly introduced system of substituting prescriptions? Ugeskrift for læger 2000;162:6066-6069 [in Danish]
17. Thiebaud P, Patel BV, Nichol MB, et al. The effect of switching on compliance and persistence: the case of statin treatment. Am J Manag Care 2005;11:670-674 (Pubitemid 41608208)
18. van Wijk BLG, Klungel OH, Heerdink ER, et al. The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens 2004;22:1831-1837
19. van Wijk BLG, Klungel OH, Heerdink ER, et al. Generic substitution of antihypertensive drugs: does it affect adherence? Ann Pharmacother 2006;40:15-20
20. Buurma H, Bouvy ML, De Smet PA, et al. Prevalence and determinants of pharmacy shopping behaviour. J Clin Pharm Ther 2008;33:17-23
21. Clifford S, Barber N, Horne R. Understanding different beliefs held by adherers, unintentional nonadherers, and intentional nonadherers: application of the necessity-concerns framework. J Psychosom Res 2008;64:41-46 (Pubitemid 350297299)
22. Krousel-Wood M, Thomas S, Muntner P, et al. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol 2004;19:357-362 (Pubitemid 38916494)
23. Grégoire JP, Moisan J, Guibert R, et al. Determinants of discontinuation of new courses of antihypertensive medications. J Clin Epidemiol 2002;55:728-735 (Pubitemid 34884161)
24. Steinman MA, Sands LP, Covinsky KE. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med 2001;16:793-799
25. Lundberg L, Johannesson M, Isacson DGL, et al. Effects of user charges on the use of prescription medicines in different socio-economic groups. Health Policy 1998;44:123-134 (Pubitemid 28275957)
26. Elliott RA, Shinogle JA, Peele P, et al. Understanding medication compliance and persistence from an economics perspective. Value Health 2008;11:600-610 (Pubitemid 352032815)
27. Garber MC, Nau DP, Erickson SR, et al. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004;42:649-652
28. Wang PS, Benner JS, Glynn RJ, et al. How well do patients report noncompliance with antihypertensive medications? a comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 2004;13:11-19
29. Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA 2008;300:2514-2526